Interferon beta-1b [interferon beta 1b]
- Terms
-
Betaferon
Extavia
interferon beta-1b
-
Beta-IFN-1b
Beta-Seron
Betaferon
Betaseron
Extavia
IFN-Beta Ser
Interferon beta 1b
Interferon Beta, Ser(17)
Interferon Beta, Serine(17)
Ser(17) IFN-beta
Serine(17) Interferon Beta
A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
- DUI
- D000068576 MeSH Browser
- CUI
- M0129586
- History note
- 2016 (1985)
- Public note
- 2016; INTERFERON BETA-1B was previously indexed under INTERFERON BETA, 1991-2015; RECOMBINANT PROTEINS, 1988-1991; and under INTERFERON TYPE I, 1985-1988
Allowable subheadings
- AD
- administration & dosage 8
- AE
- adverse effects 3
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics 1
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 10
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine